# Enable Medicine to Present Poster Presentations at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

MENLO PARK, Calif.--( [BUSINESS WIRE](https://www.businesswire.com/news/home/20231030900610/en/))-- [Enable Medicine](https://www.enablemedicine.com/), a leader in AI for biological research and drug discovery, announced today it will present a number of poster presentations at the [Society for Immunotherapy of Cancer (SITC)](https://www.sitcancer.org/home) 38th Annual Meeting being held November 1-5, 2023, in San Diego, California.

> "We are excited to showcase the capabilities of Enable Medicine’s platform in analyzing pathology and other omic data to improve our understanding of cancer biology and predict potential treatment response in patients," said Sunil Bodapati, CEO, Enable Medicine. “These study results will advance our understanding of the tumor microenvironment and empower researchers to use our comprehensive maps of disease biology to understand how the organization of cells impact disease pathology, progression, and therapeutic response.”

## Poster Presentations

### Title: From images to insights: Deep spatial profiling reveals disease and treatment biomarkers  
**Abstract Number:** #95  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

### Title: Integrative spatial multi-omics analysis of NSCLC tumor microenvironment identifies key features associated with response to immune checkpoint inhibitor therapy  
**Abstract Number:** #222  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

### Title: emObject: domain specific data abstraction for spatial omics  
**Abstract Number:** #899  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

### Title: Quantitative cell morphology featurization in multiplexed immunofluorescence images reveals tumor subtypes in cancer microenvironments  
**Abstract Number:** #1290  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

### Title: A machine learning toolkit for automated processing of multiplexed immunofluorescence images  
**Abstract Number:** #1302  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

### Title: Polarity measurements from multiplex imaging suggest immune cell activation  
**Abstract Number:** #1314  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

### Title: Identification and generalization of tissue structures with spatial cellular graph partitioning  
**Abstract Number:** #1315  
**Date / Time:** November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT  
**Location:** Exhibit Halls A and B1 – San Diego Convention Center

The full abstracts will be released on the SITC website on Tuesday, October 31, 2023 at 9:00 a.m. ET.

### About Enable Medicine

Enable Medicine harnesses the revolutionary capabilities of AI to provide cutting-edge insights into biology and medicine. Our platform finds biological signatures relevant to the asset or indication. Our global network of partners leverage the platform to guide target discovery, identify new biomarkers, and develop optimal treatment strategies. Enable Medicine is headquartered in Menlo Park, CA. Learn more at: [www.enablemedicine.com](http://enablemedicine.com/) and follow us [@EnableMedicine](https://twitter.com/EnableMedicine).